Thomas D Y Chung (Thomas Dy Chung)

Years Active: 2017-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Lester J Lambert, Stefan Grotegut, Maria Celeridad, Palak Gosalia, Laurent Js De Backer, Andrey A Bobkov, Sumeet Salaniwal, Thomas D Y Chung, Fu-Yue Zeng, Ian Pass, Paul J Lombroso, Nicholas Dp Cosford, Lutz Tautz
Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP). International journal of molecular sciences 22 (9) (2021)
Stephanie M Stanford, Alexander E Aleshin, Vida Zhang, Robert J Ardecky, Michael P Hedrick, Jiwen Zou, Santhi R Ganji, Matthew R Bliss, Fusayo Yamamoto, Andrey A Bobkov, Janna Kiselar, Yingge Liu, Gregory W Cadwell, Shilpi Khare, Jinghua Yu, Antonio Barquilla, Thomas D Y Chung, Tomas Mustelin, Simon Schenk, Laurie A Bankston, Robert C Liddington, Anthony B Pinkerton, Nunzio Bottini
Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nature chemical biology 13 (6) (2017)
Jing Li, Tanya Yakushi, Francesco Parlati, Andrew L Mackinnon, Christian Perez, Yuyong Ma, Kyle P Carter, Sharon Colayco, Gavin Magnuson, Brock Brown, Kevin Nguyen, Stefan Vasile, Eigo Suyama, Layton H Smith, Eduard Sergienko, Anthony B Pinkerton, Thomas D Y Chung, Amy E Palmer, Ian Pass, Sonja Hess, Seth M Cohen, Raymond J Deshaies
Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11. Nature chemical biology 13 (5) (2017)

Thomas D Y Chung.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas Dy Chung)